Overview Case Presentation Diagnosis Treatment – Induction phase Treatment – Continuation Phase Treatment Monitoring Assessment of Transmission Outcome.
Trends in TB R&D investment: Where is funding most needed? Lindsey Wu Policy Analyst Policy Cures [email protected] .
terpai afli bercept
CAP-TB Thailand and Regional. Rayong Province Strengthening the TB network.
Rationale for New Drugs for Tuberculosis 500,000 cases annually of MDR TB – Second line treatment toxic and weak 15% of TB is HIV-related – Drug-drug interactions.
TEMPLATE DESIGN © 2008 Increasing treatment completion of LTBI in high-risk international university students A. Anderson RN.
Another Surprise? Dr M Wansbrough-Jones Matthew Drake Mark Rooney Andrew Ladwiniec.
Jana Blumenthal Michael Dillon Kacy Negethon Abby Law.
KNCV experience with PV/aDSM Symposium 12 Suzanne Verver, Agnes Gebhard, Susan van den Hof, Gunta Dravniece, Svetlana Pak, Sandra Kik.
Statistical & Design Considerations for Non-inferiority trials Andrew Nunn MRC Clinical Trials Unit London.
Country Progress Report LAO PDR The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.
